July 26, 2018 01:09 PM EDT
Financing

Days af­ter Mer­ck deal, Sutro rolls out $85M E round to fund in­ter­nal can­cer pipeline

Brittany Meiling

Just days af­ter an­nounc­ing a deal with Mer­ck, South San Fran­cis­co’s Sutro Bio­Phar­ma is trot­ting out a siz­able in­fu­sion of cash to­day to fu­el its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times